Nanosized carriers work by encapsulating the therapeutic agent within their structure. This encapsulation protects the agent from degradation and allows for controlled release at the target site. The carriers can be functionalized with targeting ligands that recognize and bind to specific receptors on the surface of target cells, ensuring that the therapy is delivered precisely where it is needed.
